Parliament Question: Establishment of Pharmaceutical Industry

GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS LOK SABHA UNSTARRED QUESTION NO. 5720 TO BE ANSWERED ON THE 27th MARCH, 2026 Establishment of Pharmaceutical Industry †5720. Shri Gyaneshwar Patil: Smt. Delkar Kalaben Mohanbhai: Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state: (a) the measures taken by the Government under the "Aatmanirbhar Bharat Abhiyaan" to promote the establishment of new units under pharmaceutical industry along with their impact in the country, State-wise and district/UT-wise including Madhya Pradesh and Dadra and Nagar Haveli; (b) the total assistance provided by the Union Government to the Government of Madhya Pradesh and Dadra and Nagar Haveli so far for research, quality control laboratories and training of youth in the pharmaceutical sector; and (c) the steps taken by the Government to increase the availability of affordable medicines under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana in Madhya Pradesh and Dadra and Nagar Haveli? ANSWER THE MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND FERTILIZERS (SMT. ANUPRIYA PATEL) (a): The Government has launched the PLI Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs) / Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India (also known as the PLI Scheme for Bulk Drugs) to promote the establishment of new pharmaceutical industrial units. The PLI Scheme for Bulk Drugs has a budgetary outlay of ₹6,940 crore, and it aims to improve self-reliance and reduce import dependence in critical KSMs, DIs and APIs. As of December 2025, 48 greenfield projects have been approved under the scheme with committed investment of ₹4,329.95 crore, against which actual investment of ₹4,814.1 crore has been made. 38 projects have been commissioned, resulting in establishment of domestic manufacturing capacity of approximately 56,800MT per annum. Details of projects approved under PLI Scheme for Bulk Drugs, State-wise and district-wise are placed at Annexure. (b): The Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme has been launched by the Government with an outlay of ₹5,000 crore to transform India’s Pharma MedTech sector including Madhya Pradesh and Dadra and Nagar Haveli, from cost-based to innovation-based growth by strengthening research and to promote industry-academia linkagefor research and development in priority areas in drug discovery and development and medical devices. Under this, seven Centres of Excellence (CoEs) have been set up, with total budgetary support to the tune of ₹700 crore, to create research infrastructure and promote R&D in identified areas. The CoEs have so far approved 104 research projects under the scheme and have filed two patents. The scheme also includes an outlay of ₹4,250 crore for support to industry and startups, including in collaboration with academia, for undertaking research and innovation projects in priority areas. (c): The Pradhan Mantri Bhartiya Janaushadhi Pariyojana was launched by the Government of India to make quality generic medicines available at affordable prices for all citizens. Under this scheme, special outlets called Jan Aushadhi Kendras are opened across the country which provide medicines that are about 50% to 80% cheaper than branded medicines, helping reduce healthcare expenses for patients. Under the scheme, 634 JAKs in Madhya Pradesh and 41 JAKs in the Union Territory of Dadra and Nagar Haveli and Daman & Diu have been opened which aim to increase the availability of affordable medicines in Madhya Pradesh and Union Territory of Dadra and Nagar Haveli and Daman & Diu. Further, to increase availability of medicines, Pharmaceutical & Medical Devices Bureau of India (PMBI), which is the implementing agency of the PMBJP scheme, utilises an end-to-end information-technology-enabled supply chain system through which availability of medicines are monitored in these JAKs. The JAKs are incentivised to maintain the stocks of 200 high demand products under the scheme. In addition, 400 fast-moving products are monitored regularly by PMBI with periodic forecasting aided by digital tools.Annexure Annexure referred to in the reply to part (a) of the Lok Sabha Unstarred Question No. 5720, to be answered on 27.3.2026 Details of approved projects under the PLI Scheme for Bulk Drugs, State-wise and district- wise: S. Name of the Company Product District Project Location No. (State) 1. Aurobindo Pharma Penicillin G East Godavari Andhra Pradesh Limited Through Lyfius Pharma Pvt Ltd. 2. Karnataka Antibiotics 7 ACA Ujjain Madhya Pradesh and Pharmaceuticals Limited 3. Kinvan Private Limited Clavulanic Acid Solan Himachal Pradesh 4. Orchid Bio-Pharma 7 ACA Kathua Jammu & Limited Kashmir 5. Macleods Rifampicin Bharuch Gujarat Pharmaceutical Limited 6. Natural Biogenex Betamethasone Tumkur Karnataka Private Limited 7. Natural Biogenex Dexamethasone Tumkur Karnataka Private Limited 8. Natural Biogenex Prednisolone Tumkur Karnataka Private Limited 9. Symbiotec Pharmalab Prednisolone Dhar Madhya Pradesh Private Limited 10. Emmennar Pharma Pvt 1,1 Cyclohexane Sangareddy Telangana Ltd. Diacetic Acid (CDA) 11. Granules India Limited Dicyandiamide Visakhapatnam & Andhra Pradesh (DCDA) Kakinada (2 locations) 12. Hindys Lab Pvt Ltd. 1,1 Cyclohexane Nalgonda Telangana Diacetic Acid (CDA) 13. Meghmani LLP Para Amino Phenol Bharuch Gujarat 14. Sadhana Nitro Chem Para Amino Phenol Raigad Maharashtra Ltd. 15. Alta Laboratories Aspirin Raigad Maharashtra Limited 16. Amoli Organics Private Diclofenac Sodium Valsad Gujarat Limited 17. Anasia Lab Private Losartan Nalgonda Telangana Limited18. Anasia Lab Private Olmesartan Nalgonda Telangana Limited 19. Andhra Organics Olmesartan Srikakulam Andhra Pradesh Limited 20. Andhra Organics Sulfadiazine Srikakulam Andhra Pradesh Limited 21. Andhra Organics Telmisartan Srikakulam Andhra Pradesh Limited 22. Aviran Pharmachem Artesunate Mehsana Gujarat Private Limited 23. Centrient Atorvastatin Nawanshahr Punjab Pharmaceuticals India Private Limited 24. Dasami Lab Pvt Ltd. Carbamazepine Nalgonda Telangana 25. Dasami Lab Pvt Ltd. Oxcarbazepine Nalgonda Telangana 26. Global Pharma Ofloxacin Tiruvannamalai Tamil Nadu Healthcare Private Limited 27. Globela Industries Pvt Norfloxacin Bharuch Gujarat Ltd 28. Globela Industries Pvt Ofloxacin Bharuch Gujarat Ltd 29. Hazelo Lab Pvt Ltd. Vitamin B6 Yadadri Telangana 30. Hetero Drugs Limited Carbidopa Visakhapatnam Andhra Pradesh 31. Hetero Drugs Limited Levodopa Visakhapatnam Andhra Pradesh 32. Hetero Drugs Limited Levofloxacin Sangareddy Telangana 33. Hetero Drugs Limited Oxcarbazepine Sangareddy Telangana 34. Hindys Lab Pvt Ltd. Acyclovir Nalgonda Telangana 35. Honour Lab Limited Levetiracetam Sangareddy Telangana 36. Honour Lab Limited Lopinavir Visakhapatnam Andhra Pradesh 37. Honour Lab Limited Valsartan Sangareddy Telangana 38. Honour Lab Limited Vitamin B6 Visakhapatnam Andhra Pradesh 39. K P Manish Global Artesunate Cuddalore Tamil Nadu Ingredients Pvt Ltd. 40. Kreative Actives Private Diclofenac Sodium Visakhapatnam Andhra Pradesh Limited 41. MSN Life Sciences Pvt Levofloxacin Medak Telangana Ltd. 42. RMC Performance Aspirin Jalgaon Maharashtra Chemicals Private Limited 43. Sudarshan Pharma Vitamin B1 Raigad Maharashtra Industries Ltd. (Chemical Synthesis Route) 44. Sudarshan Pharma Vitamin B6 Raigad Maharashtra Industries Ltd. 45. Vital Laboratories Levofloxacin Valsad Gujarat Private Limited46. Vital Laboratories Ofloxacin Valsad Gujarat Private Limited 47. Sustainable Erythromycin SAS Nagar Punjab Environment Developers Thiocynate (TIOC) Limited 48. Orgo Pharma and Fuels 2-Methyl-5Nitro- Yamuna Nagar Haryana LLP Imidazole (2-MNI) *****